Literature DB >> 3700596

Sensitive and specific monoclonal immunoassay for detecting yellow fever virus in laboratory and clinical specimens.

T P Monath, L J Hill, N V Brown, C B Cropp, J J Schlesinger, J F Saluzzo, J R Wands.   

Abstract

A solid-phase radioimmunoassay (RIA) was developed for the detection of yellow fever (YF) virus in infected cell culture supernatant fluid and clinical samples. The test employed a flavivirus group-reactive monoclonal antibody attached to a polystyrene bead support and a radiolabeled type-specific antibody probe in a simultaneous sandwich RIA format. Optimal assay conditions specified a 16-h incubation at high temperature (45 degrees C). Monoclonal antibody to tetanus toxoid was added to the radiolabeled probe to inhibit nonspecific binding. The sensitivity of the assay for cell culture-propagated virus was 2.0 log10 50% mosquito infectious doses per 100 microliters or 100 pg of gradient-purified virion protein per 100 microliters. Specificity, assessed with human sera from 512 patients with liver diseases other than YF, including acute viral hepatitis, showed a false-positive rate of 0.0 to 0.6%. Sera from experimentally infected rhesus macaques containing greater than 3.0 log10 units/100 microliter of YF virus were positive by RIA. Sera and liver tissue from human patients were found to be positive.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3700596      PMCID: PMC268586          DOI: 10.1128/jcm.23.1.129-134.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS.

Authors:  E F WHEELOCK; W A SIBLEY
Journal:  N Engl J Med       Date:  1965-07-22       Impact factor: 91.245

2.  The hemagglutinin of St. Louis encephalitis virus. II. Physico-chemical properties and nature of its reaction with erythrocytes.

Authors:  R M CHANOCK; A B SABIN
Journal:  J Immunol       Date:  1953-03       Impact factor: 5.422

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

5.  Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence.

Authors:  T P Monath; J J Schlesinger; M W Brandriss; C B Cropp; W C Prange
Journal:  Am J Trop Med Hyg       Date:  1984-07       Impact factor: 2.345

6.  Analysis of 17D yellow fever virus envelope protein epitopes using monoclonal antibodies.

Authors:  J J Schlesinger; E E Walsh; M W Brandriss
Journal:  J Gen Virol       Date:  1984-10       Impact factor: 3.891

7.  Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.

Authors:  J J Schlesinger; M W Brandriss; T P Monath
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

8.  Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced world-wide.

Authors:  T P Monath; R M Kinney; J J Schlesinger; M W Brandriss; P Brès
Journal:  J Gen Virol       Date:  1983-03       Impact factor: 3.891

9.  FURTHER STUDIES ON ANTIGENIC RELATIONSHIPS AMONG THE VIRUSES OF THE GROUP B TICK-BORNE COMPLEX.

Authors:  D H CLARKE
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  2 in total

1.  Detection of St. Louis encephalitis virus antigen in mosquitoes by capture enzyme immunoassay.

Authors:  T F Tsai; R A Bolin; M Montoya; R E Bailey; D B Francy; M Jozan; J T Roehrig
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

2.  Evaluation of enzyme-linked immunosorbent assay and reversed passive hemagglutination for detection of Crimean-Congo hemorrhagic fever virus antigen.

Authors:  A J Shepherd; R Swanepoel; D E Gill
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.